ZBTB42 is a zinc finger transcriptional repressor that functions as a DNA-binding protein, likely recruiting chr14 remodeling complexes to regulate gene expression 1. The protein is predominantly expressed in skeletal muscle and ovary, with nuclear localization and particular enrichment in nuclei underlying neuromuscular junctions 1. ZBTB42 plays a critical role in skeletal muscle development, as zebrafish zbtb42 knockdown results in grossly abnormal muscle development and myofibrillar disorganization, phenotypes successfully rescued by wild-type human ZBTB42 overexpression 2. Genetically, ZBTB42 variants associate with metabolic syndrome, with polymorphisms modulating transcriptional activity in a cell-type and differentiation-specific manner, demonstrating tissue-specific metabolic effects 3. Clinically, ZBTB42 mutations cause lethal congenital contracture syndrome type 6 (LCCS6), an autosomal recessive form of arthrogryposis multiplex congenita characterized by severe skeletal muscle defects 2. The discovery that pathogenic missense variants fail to rescue the muscle developmental phenotype observed with knockdown suggests ZBTB42 mutations abolish essential muscle developmental functions. These findings establish ZBTB42 as a crucial regulator linking transcriptional control to both normal muscle development and metabolic homeostasis.